Altium Capital Management »

Tc Biopharm Holdings shares owned by Altium Capital Management

Quarter-by-quarter ownership of Tc Biopharm Holdings (TCBPW) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Tc Biopharm Holdings

Tip: Access up to 7 years of quarterly data

All positions including Tc Biopharm Holdings held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tc Biopharm Holdings by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $393 19k 0.02
2023-06-30 $809 19k 0.04
2023-03-31 $1.9k 19k 0.10
2022-12-31 $1.7k 19k 0.09
2022-09-30 $118k 941k 0.13
2022-06-30 $223k 941k 0.24
2022-03-31 $461k 941k 0.49

More positions owned by Altium Capital Management

Cymabay Therapeutics
Immunovant Put Put Option
ImmunoGen
Astria Therapeutics (ATXS)
Xtant Med Hldgs Com New (XTNT)
Amylyx Pharmaceuticals (AMLX)
Adma Biologics (ADMA)
Alimera Sciences Com New (ALIM)
Structure Therapeutics Sponsored Ads (GPCR)
Crinetics Pharmaceuticals In (CRNX)
Xenon Pharmaceuticals (XENE)
Biohaven (BHVN)
Axsome Therapeutics (AXSM)
Karuna Therapeutics Ord
Moonlake Immunotherapeutics Class A Ord (MLTX)

View all positions for Altium Capital Management

Top funds holding Tc Biopharm Holdings

Kepos Capital
Nantahala Capital Management
Virtu Financial
UBS Group
Bank of America Corporation

View all funds holding Tc Biopharm Holdings